Pre-order Enquiry
Request Free Sample
Global Cerebral Malaria Therapeutics Market Outlook 2022
SKU ID : QYR-19624215 | Publishing Date : 30-Nov-2021 | No. of pages : 101
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Cerebral Malaria Therapeutics Market Outlook 2022
1 Cerebral Malaria Therapeutics Market Overview1.1 Product Overview and Scope of Cerebral Malaria Therapeutics
1.2 Cerebral Malaria Therapeutics Segment by Type
1.2.1 Global Cerebral Malaria Therapeutics Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Quinine
1.2.3 Artemisinin Derivatives
1.3 Cerebral Malaria Therapeutics Segment by Application
1.3.1 Global Cerebral Malaria Therapeutics Sales Comparison by Application: (2021-2027)
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.3.4 Hospital Pharmacies
1.3.5 Drug Store
1.4 Global Cerebral Malaria Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Cerebral Malaria Therapeutics Revenue 2016-2027
1.4.2 Global Cerebral Malaria Therapeutics Sales 2016-2027
1.4.3 Cerebral Malaria Therapeutics Market Size by Region: 2016 Versus 2021 Versus 2027
2 Cerebral Malaria Therapeutics Market Competition by Manufacturers
2.1 Global Cerebral Malaria Therapeutics Sales Market Share by Manufacturers (2016-2021)
2.2 Global Cerebral Malaria Therapeutics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Cerebral Malaria Therapeutics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Cerebral Malaria Therapeutics Manufacturing Sites, Area Served, Product Type
2.5 Cerebral Malaria Therapeutics Market Competitive Situation and Trends
2.5.1 Cerebral Malaria Therapeutics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cerebral Malaria Therapeutics Players Market Share by Revenue
2.5.3 Global Cerebral Malaria Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cerebral Malaria Therapeutics Retrospective Market Scenario by Region
3.1 Global Cerebral Malaria Therapeutics Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Cerebral Malaria Therapeutics Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Cerebral Malaria Therapeutics Market Facts & Figures by Country
3.3.1 North America Cerebral Malaria Therapeutics Sales by Country
3.3.2 North America Cerebral Malaria Therapeutics Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cerebral Malaria Therapeutics Market Facts & Figures by Country
3.4.1 Europe Cerebral Malaria Therapeutics Sales by Country
3.4.2 Europe Cerebral Malaria Therapeutics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cerebral Malaria Therapeutics Market Facts & Figures by Region
3.5.1 Asia Pacific Cerebral Malaria Therapeutics Sales by Region
3.5.2 Asia Pacific Cerebral Malaria Therapeutics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Cerebral Malaria Therapeutics Market Facts & Figures by Country
3.6.1 Latin America Cerebral Malaria Therapeutics Sales by Country
3.6.2 Latin America Cerebral Malaria Therapeutics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cerebral Malaria Therapeutics Market Facts & Figures by Country
3.7.1 Middle East and Africa Cerebral Malaria Therapeutics Sales by Country
3.7.2 Middle East and Africa Cerebral Malaria Therapeutics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Cerebral Malaria Therapeutics Historic Market Analysis by Type
4.1 Global Cerebral Malaria Therapeutics Sales Market Share by Type (2016-2021)
4.2 Global Cerebral Malaria Therapeutics Revenue Market Share by Type (2016-2021)
4.3 Global Cerebral Malaria Therapeutics Price by Type (2016-2021)
5 Global Cerebral Malaria Therapeutics Historic Market Analysis by Application
5.1 Global Cerebral Malaria Therapeutics Sales Market Share by Application (2016-2021)
5.2 Global Cerebral Malaria Therapeutics Revenue Market Share by Application (2016-2021)
5.3 Global Cerebral Malaria Therapeutics Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Cerebral Malaria Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Cerebral Malaria Therapeutics Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Cipla
6.2.1 Cipla Corporation Information
6.2.2 Cipla Description and Business Overview
6.2.3 Cipla Cerebral Malaria Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Cipla Cerebral Malaria Therapeutics Product Portfolio
6.2.5 Cipla Recent Developments/Updates
6.3 Zydus Cadila
6.3.1 Zydus Cadila Corporation Information
6.3.2 Zydus Cadila Description and Business Overview
6.3.3 Zydus Cadila Cerebral Malaria Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Zydus Cadila Cerebral Malaria Therapeutics Product Portfolio
6.3.5 Zydus Cadila Recent Developments/Updates
6.4 Ipca Laboratories
6.4.1 Ipca Laboratories Corporation Information
6.4.2 Ipca Laboratories Description and Business Overview
6.4.3 Ipca Laboratories Cerebral Malaria Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ipca Laboratories Cerebral Malaria Therapeutics Product Portfolio
6.4.5 Ipca Laboratories Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Cerebral Malaria Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Sanofi Cerebral Malaria Therapeutics Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Eisai
6.6.1 Eisai Corporation Information
6.6.2 Eisai Description and Business Overview
6.6.3 Eisai Cerebral Malaria Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Eisai Cerebral Malaria Therapeutics Product Portfolio
6.6.5 Eisai Recent Developments/Updates
7 Cerebral Malaria Therapeutics Manufacturing Cost Analysis
7.1 Cerebral Malaria Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cerebral Malaria Therapeutics
7.4 Cerebral Malaria Therapeutics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cerebral Malaria Therapeutics Distributors List
8.3 Cerebral Malaria Therapeutics Customers
9 Cerebral Malaria Therapeutics Market Dynamics
9.1 Cerebral Malaria Therapeutics Industry Trends
9.2 Cerebral Malaria Therapeutics Growth Drivers
9.3 Cerebral Malaria Therapeutics Market Challenges
9.4 Cerebral Malaria Therapeutics Market Restraints
10 Global Market Forecast
10.1 Cerebral Malaria Therapeutics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cerebral Malaria Therapeutics by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Cerebral Malaria Therapeutics by Type (2022-2027)
10.2 Cerebral Malaria Therapeutics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cerebral Malaria Therapeutics by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Cerebral Malaria Therapeutics by Application (2022-2027)
10.3 Cerebral Malaria Therapeutics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cerebral Malaria Therapeutics by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Cerebral Malaria Therapeutics by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Cerebral Malaria Therapeutics Market Outlook 2022
List of TablesTable 1. Global Cerebral Malaria Therapeutics Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Cerebral Malaria Therapeutics Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Cerebral Malaria Therapeutics Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Cerebral Malaria Therapeutics Covered in This Study
Table 5. Global Cerebral Malaria Therapeutics Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Cerebral Malaria Therapeutics Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Cerebral Malaria Therapeutics Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Cerebral Malaria Therapeutics Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Cerebral Malaria Therapeutics Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Cerebral Malaria Therapeutics Manufacturing Sites and Area Served
Table 11. Manufacturers Cerebral Malaria Therapeutics Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Cerebral Malaria Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cerebral Malaria Therapeutics as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Cerebral Malaria Therapeutics Sales by Region (2016-2021) & (K MT)
Table 16. Global Cerebral Malaria Therapeutics Sales Market Share by Region (2016-2021)
Table 17. Global Cerebral Malaria Therapeutics Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Cerebral Malaria Therapeutics Sales by Country (2016-2021) & (K MT)
Table 19. North America Cerebral Malaria Therapeutics Sales Market Share by Country (2016-2021)
Table 20. North America Cerebral Malaria Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Cerebral Malaria Therapeutics Revenue Market Share by Country (2016-2021)
Table 22. Europe Cerebral Malaria Therapeutics Sales by Country (2016-2021) & (K MT)
Table 23. Europe Cerebral Malaria Therapeutics Sales Market Share by Country (2016-2021)
Table 24. Europe Cerebral Malaria Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Cerebral Malaria Therapeutics Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Cerebral Malaria Therapeutics Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Cerebral Malaria Therapeutics Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Cerebral Malaria Therapeutics Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Cerebral Malaria Therapeutics Revenue Market Share by Region (2016-2021)
Table 30. Latin America Cerebral Malaria Therapeutics Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Cerebral Malaria Therapeutics Sales Market Share by Country (2016-2021)
Table 32. Latin America Cerebral Malaria Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Cerebral Malaria Therapeutics Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Cerebral Malaria Therapeutics Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Cerebral Malaria Therapeutics Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Cerebral Malaria Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Cerebral Malaria Therapeutics Revenue Market Share by Country (2016-2021)
Table 38. Global Cerebral Malaria Therapeutics Sales (K MT) by Type (2016-2021)
Table 39. Global Cerebral Malaria Therapeutics Sales Market Share by Type (2016-2021)
Table 40. Global Cerebral Malaria Therapeutics Revenue (Million US$) by Type (2016-2021)
Table 41. Global Cerebral Malaria Therapeutics Revenue Share by Type (2016-2021)
Table 42. Global Cerebral Malaria Therapeutics Price (USD/MT) by Type (2016-2021)
Table 43. Global Cerebral Malaria Therapeutics Sales (K MT) by Application (2016-2021)
Table 44. Global Cerebral Malaria Therapeutics Sales Market Share by Application (2016-2021)
Table 45. Global Cerebral Malaria Therapeutics Revenue (Million US$) by Application (2016-2021)
Table 46. Global Cerebral Malaria Therapeutics Revenue Share by Application (2016-2021)
Table 47. Global Cerebral Malaria Therapeutics Price (USD/MT) by Application (2016-2021)
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Business Overview
Table 50. Novartis Cerebral Malaria Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Novartis Cerebral Malaria Therapeutics Product
Table 52. Novartis Recent Developments/Updates
Table 53. Cipla Corporation Information
Table 54. Cipla Description and Business Overview
Table 55. Cipla Cerebral Malaria Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Cipla Cerebral Malaria Therapeutics Product
Table 57. Cipla Recent Developments/Updates
Table 58. Zydus Cadila Corporation Information
Table 59. Zydus Cadila Description and Business Overview
Table 60. Zydus Cadila Cerebral Malaria Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Zydus Cadila Cerebral Malaria Therapeutics Product
Table 62. Zydus Cadila Recent Developments/Updates
Table 63. Ipca Laboratories Corporation Information
Table 64. Ipca Laboratories Description and Business Overview
Table 65. Ipca Laboratories Cerebral Malaria Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Ipca Laboratories Cerebral Malaria Therapeutics Product
Table 67. Ipca Laboratories Recent Developments/Updates
Table 68. Sanofi Corporation Information
Table 69. Sanofi Description and Business Overview
Table 70. Sanofi Cerebral Malaria Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Sanofi Cerebral Malaria Therapeutics Product
Table 72. Sanofi Recent Developments/Updates
Table 73. Eisai Corporation Information
Table 74. Eisai Description and Business Overview
Table 75. Eisai Cerebral Malaria Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Eisai Cerebral Malaria Therapeutics Product
Table 77. Eisai Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Cerebral Malaria Therapeutics Distributors List
Table 81. Cerebral Malaria Therapeutics Customers List
Table 82. Cerebral Malaria Therapeutics Market Trends
Table 83. Cerebral Malaria Therapeutics Growth Drivers
Table 84. Cerebral Malaria Therapeutics Market Challenges
Table 85. Cerebral Malaria Therapeutics Market Restraints
Table 86. Global Cerebral Malaria Therapeutics Sales Forecast by Type (2022-2027) & (K MT)
Table 87. Global Cerebral Malaria Therapeutics Sales Market Share Forecast by Type (2022-2027)
Table 88. Global Cerebral Malaria Therapeutics Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 89. Global Cerebral Malaria Therapeutics Revenue Market Share Forecast by Type (2022-2027)
Table 90. Global Cerebral Malaria Therapeutics Sales Forecast by Application (2022-2027) & (K MT)
Table 91. Global Cerebral Malaria Therapeutics Sales Market Share Forecast by Application (2022-2027)
Table 92. Global Cerebral Malaria Therapeutics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 93. Global Cerebral Malaria Therapeutics Revenue Market Share Forecast by Application (2022-2027)
Table 94. Global Cerebral Malaria Therapeutics Sales Forecast by Region (2022-2027) & (K MT)
Table 95. Global Cerebral Malaria Therapeutics Sales Market Share Forecast by Region (2022-2027)
Table 96. Global Cerebral Malaria Therapeutics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 97. Global Cerebral Malaria Therapeutics Revenue Market Share Forecast by Region (2022-2027)
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cerebral Malaria Therapeutics
Figure 2. Global Cerebral Malaria Therapeutics Market Share by Type in 2020 & 2027
Figure 3. Quinine Product Picture
Figure 4. Artemisinin Derivatives Product Picture
Figure 5. Global Cerebral Malaria Therapeutics Market Share by Application in 2020 & 2027
Figure 6. Retail Pharmacies
Figure 7. Online Pharmacies
Figure 8. Hospital Pharmacies
Figure 9. Drug Store
Figure 10. Global Cerebral Malaria Therapeutics Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Cerebral Malaria Therapeutics Market Size 2016-2027 (US$ Million)
Figure 12. Global Cerebral Malaria Therapeutics Sales 2016-2027 (K MT)
Figure 13. Global Cerebral Malaria Therapeutics Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Cerebral Malaria Therapeutics Sales Share by Manufacturers in 2020
Figure 15. Global Cerebral Malaria Therapeutics Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Cerebral Malaria Therapeutics Players: Market Share by Revenue in 2020
Figure 17. Cerebral Malaria Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Cerebral Malaria Therapeutics Sales Market Share by Region (2016-2021)
Figure 19. Global Cerebral Malaria Therapeutics Sales Market Share by Region in 2020
Figure 20. Global Cerebral Malaria Therapeutics Revenue Market Share by Region (2016-2021)
Figure 21. Global Cerebral Malaria Therapeutics Revenue Market Share by Region in 2020
Figure 22. U.S. Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Cerebral Malaria Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Cerebral Malaria Therapeutics by Type (2016-2021)
Figure 47. Sales Market Share of Cerebral Malaria Therapeutics by Application (2016-2021)
Figure 48. Sales Market Share of Cerebral Malaria Therapeutics by Application in 2020
Figure 49. Revenue Share of Cerebral Malaria Therapeutics by Application (2016-2021)
Figure 50. Revenue Share of Cerebral Malaria Therapeutics by Application in 2020
Figure 51. Manufacturing Cost Structure of Cerebral Malaria Therapeutics
Figure 52. Manufacturing Process Analysis of Cerebral Malaria Therapeutics
Figure 53. Cerebral Malaria Therapeutics Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Keyplayers in Global Cerebral Malaria Therapeutics Market Outlook 2022
NovartisCipla
Zydus Cadila
Ipca Laboratories
Sanofi
Eisai
